Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Otsuka Of Japan Opens Intermediaries Plant In India

This article was originally published in PharmAsia News

Executive Summary

Japan's Otsuka Pharmaceutical opened a plant in India to produce antibiotic intermediaries for sale to local Indian drug makers. The $48 million plant is capable of producing 500 tons of the intermediaries to meet a growing demand by Indian drug makers in the process of a global expansion. Until the Indian plant opened, with initial production set at 300 tons, Otsuka had been supplying Indian drug makers from production facilities in Japan. (Click here for more - a subscription may be required

Japan's Otsuka Pharmaceutical opened a plant in India to produce antibiotic intermediaries for sale to local Indian drug makers. The $48 million plant is capable of producing 500 tons of the intermediaries to meet a growing demand by Indian drug makers in the process of a global expansion. Until the Indian plant opened, with initial production set at 300 tons, Otsuka had been supplying Indian drug makers from production facilities in Japan. (Click here for more - a subscription may be required)

"Otsuka Chem Starting Indian Output Of Antibiotic Intermediates" - Nikkei (Japan) (5/16/08)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel